U-Shaped Associations Between Urinary Iodine Concentration and the Prevalence of Metabolic Disorders: A Cross-Sectional Study
- 1 July 2020
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 30 (7), 1053-1065
- https://doi.org/10.1089/thy.2019.0516
Abstract
Background: Iodine is important in both thyroid function and human metabolism. Studies have explored the effect of iodine on metabolic disorders through thyroid function. This study aimed to investigate the relationship between iodine status and metabolic disorders, such as metabolic syndrome (MetS), hypertension, impaired glucose metabolism, central obesity, and dyslipidemia. Methods: A total of 51,795 subjects aged >= 18 years from the TIDE (Thyroid Disorders, Iodine Status and Diabetes, a national epidemiological cross-sectional study) program were included. The prevalence of metabolic disorders and its related diseases was calculated based on the level of urinary iodine concentrations (UICs) using the chi-square method. To further explore whether the prevalence was associated with UIC, quadratic and UIC-stratified logistic regression models were used. Results: The prevalence of metabolic disorders as a function of UIC was found to be U-shaped with a lower prevalence of 76.0% at an UIC of 300-499 mu g/L. Participants with an UIC of 300-499 mu g/L showed an association with metabolic disorders (odds ratio [OR] = 0.857, 95% confidence interval [CI 0.796-0.922]) and hypertension (OR = 0.873 [CI 0.814-0.936]). An UIC of 300-799 mu g/L was found to be associated with the occurrence of MetS and impaired glucose tolerance. An UIC of 500-799 mu g/L was associated with the occurrence of prediabetes (OR = 0.883 [CI 0.797-0.978]). An UIC of >= 300 mu g/L was associated with the occurrence of hypertriglyceridemia, hypercholesterolemia, and high levels of low-density lipoprotein cholesterol. Furthermore, an UIC of <100 mu g/L showed an association with hypertension (OR = 1.097 [CI 1.035-1.162]) and hypercholesterolemia (OR = 1.178 [CI 1.117-1.242]). Conclusions: The association between UICs in adults and metabolic disorders and its related diseases is U-shaped. The association between UIC and metabolic disorders disappears in cases of iodine deficiency (= 500 mu g/L).This publication has 31 references indexed in Scilit:
- The Extrathyronine Actions of Iodine as Antioxidant, Apoptotic, and Differentiation Factor in Various TissuesThyroid®, 2013
- A lowered salt intake does not compromise iodine status in Cape Town, South Africa, where salt iodization is mandatoryNutrition, 2013
- Effect of dietary iodine on thyroid hormones and energy blood metabolites in lactating goatsAnimal, 2013
- Urinary Iodine is Associated with Insulin Resistance in Subjects with Diabetes Mellitus Type 2Experimental and Clinical Endocrinology & Diabetes, 2012
- Iodine status and its correlations with age, blood pressure, and thyroid volume in South Indian women above 35 years of age (Amrita Thyroid Survey)Indian Journal of Endocrinology and Metabolism, 2011
- The Impact of Dietary Iodine Intake on Lipid Metabolism in MiceBiological Trace Element Research, 2010
- Oxidative stress and metabolic syndromeLife Sciences, 2009
- Iodide accumulation provides kelp with an inorganic antioxidant impacting atmospheric chemistryProceedings of the National Academy of Sciences of the United States of America, 2008
- Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States AdultsCirculation, 2004
- Therapie der Jodmangelstruma bei Jugendlichen mit Jodid oder einer Kombination von Jodid und Levothyroxin unter besonderer Berücksichtigung der LipidparameterKlinische Padiatrie, 1996